Platinum Investment Management LTD Orchard Therapeutics PLC Transaction History

Platinum Investment Management LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$0.7 - $1.51 $934,621 - $2.02 Million	-1,335,174 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$1.16 - $2.23 $297,956 - $572,795	256,859 Added 23.82%	1,335,174 $1.76 Million
Q3 2021 Nov 09, 2021	BUY	$2.24 - $4.29 $730,703 - $1.4 Million	326,207 Added 43.37%	1,078,315 $2.48 Million
Q2 2021 Aug 11, 2021	BUY	$4.39 - $7.23 $553,750 - $911,984	126,139 Added 20.15%	752,108 $3.3 Million
Q1 2021 May 13, 2021	SELL	$4.39 - $9.08 $219,499 - $454,000	-50,000 Reduced 7.4%	625,969 $4.55 Million
Q4 2020 Feb 12, 2021	BUY	$3.86 - $5.07 $1.02 Million - $1.34 Million	263,992 Added 64.08%	675,969 $2.92 Million
Q3 2020 Nov 13, 2020	BUY	$4.11 - $6.45 $225,873 - $354,472	54,957 Added 15.39%	411,977 $1.69 Million
Q2 2020 Aug 06, 2020	BUY	$5.75 - $11.99 $1.25 Million - $2.62 Million	218,193 Added 157.17%	357,020 $2.14 Million
Q1 2020 May 15, 2020	BUY	$5.65 - $15.71 $784,372 - $2.18 Million	138,827 New	138,827 $1.05 Million

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Platinum Investment Management LTD, based on Form 13F filings with the SEC.

Stay updated on Platinum Investment Management LTD with notifications on news.